Product Overview
Best Anabolic Steroids lists GP Clomiphene from Geneza Pharmaceuticals: 30 tablets of clomiphene citrate at 50 mg, the recovery drug usually sold as Clomid. It is not a steroid and it contains no androgen. Its entire purpose in a cycle is to persuade the pituitary to release the two hormones that tell the testes to work again, which is why it appears at the end of a course rather than during one.
The mechanism is indirect, and that is the part worth understanding. Estrogen in the hypothalamus normally provides negative feedback: when it is high, gonadotropin release is restrained. Clomiphene blocks the estrogen receptor at that site, so the brain reads the signal as low and responds by raising luteinising hormone and follicle stimulating hormone. Testosterone production follows. The drug never supplies hormone itself, and it never touches the muscle tissue that the cycle was building.
Two practical consequences follow. The first is that the effect is at its strongest once the suppressive compounds have cleared, which is why the start date is tied to the ester rather than to the calendar. The second is the long tail: one isomer of clomiphene has a half-life measured in days and detectable metabolites that were still present in urine for over 261 days in a study of men, far beyond the point at which the user feels normal. GP Nolvadex is the other half of the standard recovery pair, and the two are often combined rather than chosen between.
Dosage Protocol
The schedule below restates the reference material for recovery in men. Clomiphene is a prescription substance, and in sports use the figures are orientation rather than a clinical plan.
| Beginner | 50 mg a day for four weeks, which is the standard shape of a recovery course |
| Intermediate | 50-100 mg a day for four weeks, with the higher amount used only in the opening days after deep suppression |
| Advanced | 100 mg a day at the start, dropping to 50 mg a day, across four to six weeks where the cycle was long and heavy |
| Female | Not a bodybuilding protocol: the drug is used clinically to induce ovulation and has no place in a female cycle |
| Administration | By mouth once a day, in the morning; enterohepatic circulation keeps the compound active longer than its half-life suggests |
Timing the first tablet is the decision that matters most. Starting while a long ester is still releasing means competing with the very suppression the drug is meant to reverse, and the user experiences a month of therapy that appears to do nothing. Waiting until the ester has cleared, and confirming that with a hormone panel, is what turns the course into a measurable event rather than an act of faith.
Morning dosing is a small piece of housekeeping that improves tolerance: nausea and sleeplessness are both described as possible effects, and taking the tablet early leaves the day to absorb them. A lipid and liver panel before the course is worth having, since the follow-up comparison depends on a baseline.
Suggested Protocols
Clomiphene is a recovery product, so the arrangements below are about what it follows and what it is paired with, not about what it stacks towards.
What to Expect
- LH and FSH move first. The rise in the two signalling hormones is measurable by the end of the first or second week, with testosterone following behind.
- Testosterone can rise sharply. In hypogonadal men the sources describe an increase of roughly two to two and a half times the starting level.
- The effect holds through the day. Recycling of the drug through the liver keeps it active between doses, which is part of why a single daily tablet is enough.
- Flushing and mood swings are common. Emotional variability and hot flushes are the complaints most often reported during a course.
- Vision should be watched. Blurring, double vision or light sensitivity are described in a small percentage of users and are a reason to stop rather than to continue.
- Detection has a long tail. Metabolites have been found in urine more than 261 days after dosing, which matters to anyone subject to testing.
Side Effects and Management
Most of the list is tolerable and dose-related; one item is not, and it concerns the eyes.
Post-Cycle Therapy
This product is the therapy, so the section is about the shape of the course rather than about what follows it. The single most common failure is starting too early, before the suppressive ester has finished releasing.
